64.78
price up icon11.20%   6.525
after-market アフターアワーズ: 67.87 3.095 +4.78%
loading
前日終値:
$58.25
開ける:
$60.07
24時間の取引高:
894.07K
Relative Volume:
3.57
時価総額:
$1.93B
収益:
-
当期純損益:
$-91.00M
株価収益率:
-16.36
EPS:
-3.9598
ネットキャッシュフロー:
$-74.38M
1週間 パフォーマンス:
+41.12%
1か月 パフォーマンス:
+29.73%
6か月 パフォーマンス:
+117.44%
1年 パフォーマンス:
+33.06%
1日の値動き範囲:
Value
$57.91
$65.25
1週間の範囲:
Value
$44.81
$65.25
52週間の値動き範囲:
Value
$25.60
$77.60

Disc Medicine Inc Stock (IRON) Company Profile

Name
名前
Disc Medicine Inc
Name
セクター
Healthcare (1182)
Name
電話
(617) 674-9274
Name
住所
321 ARSENAL STREET, SUITE 101, WATERTOWN
Name
職員
78
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
IRON's Discussions on Twitter

Disc Medicine Inc Stock (IRON) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-22 開始されました Wells Fargo Overweight
2024-04-01 ダウングレード Raymond James Strong Buy → Outperform
2023-12-19 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-06-09 アップグレード Raymond James Outperform → Strong Buy
2023-06-07 開始されました H.C. Wainwright Buy
2023-05-17 開始されました Raymond James Outperform
2023-04-28 開始されました Cantor Fitzgerald Overweight
2023-04-21 開始されました Stifel Buy
2023-04-20 開始されました Morgan Stanley Overweight
2023-03-23 開始されました BMO Capital Markets Outperform
2023-02-28 開始されました SVB Securities Outperform
すべてを表示

Disc Medicine Inc (IRON) 最新ニュース

pulisher
04:27 AM

Disc Medicine (NASDAQ:IRON) Stock Price Up 7%Here's Why - MarketBeat

04:27 AM
pulisher
10:37 AM

Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright - MarketBeat

10:37 AM
pulisher
10:32 AM

Scotiabank upgrades Disc Medicine shares target on trial update By Investing.com - Investing.com UK

10:32 AM
pulisher
09:17 AM

Disc Medicine Announces Multiple Presentations Across - GlobeNewswire

09:17 AM
pulisher
09:00 AM

Disc Medicine to Present Complete DISC-0974 Trial Data, Portfolio Updates at ASH 2024 | IRON Stock News - StockTitan

09:00 AM
pulisher
07:49 AM

Disc Medicine (NASDAQ:IRON) Upgraded to Overweight at Morgan Stanley - MarketBeat

07:49 AM
pulisher
Nov 04, 2024

Wedbush Reaffirms Outperform Rating for Disc Medicine (NASDAQ:IRON) - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Disc over the moon as FDA urges Apollo bid with bitopertin in EPP - BioWorld Online

Nov 04, 2024
pulisher
Nov 04, 2024

FDA aligns with Disc Medicine on EPP treatment study By Investing.com - Investing.com Canada

Nov 04, 2024
pulisher
Nov 04, 2024

Disc Medicine stock rallies 26% on FDA update for bitopertin (update) - Seeking Alpha

Nov 04, 2024
pulisher
Nov 04, 2024

Disc Medicine Shares Rise After Positive Feedback From FDA - MarketWatch

Nov 04, 2024
pulisher
Nov 04, 2024

Disc Medicine (NASDAQ:IRON) Shares Gap UpShould You Buy? - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Disc Medicine leaps as it gets positive FDA feedback - The Pharma Letter

Nov 04, 2024
pulisher
Nov 04, 2024

Raymond James increases Disc Medicine shares to Strong Buy on new drug - Investing.com UK

Nov 04, 2024
pulisher
Nov 04, 2024

Disc Medicine (NASDAQ:IRON) Rating Increased to Strong-Buy at Raymond James - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

FDA aligns with Disc Medicine on EPP treatment study - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Disc Medicine Gains FDA Support for Bitopertin Trial - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Disc Medicine Announces Successful End of Phase 2 Meeting - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval - StockTitan

Nov 04, 2024
pulisher
Nov 02, 2024

(IRON) Technical Data - Stock Traders Daily

Nov 02, 2024
pulisher
Nov 01, 2024

Disc Medicine to Host Conference Call on End of Phase 2 FDA - GlobeNewswire

Nov 01, 2024
pulisher
Nov 01, 2024

Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP) - StockTitan

Nov 01, 2024
pulisher
Nov 01, 2024

Disc Medicine, Inc. (NASDAQ:IRON) Short Interest Update - Defense World

Nov 01, 2024
pulisher
Oct 31, 2024

Disc Medicine, Inc. (NASDAQ:IRON) Short Interest Down 6.9% in October - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Disc Medicine’s (IRON) “Buy” Rating Reiterated at HC Wainwright - Defense World

Oct 31, 2024
pulisher
Oct 29, 2024

Recent Investment Analysts’ Ratings Updates for Disc Medicine (IRON) - Defense World

Oct 29, 2024
pulisher
Oct 28, 2024

Disc Medicine's SWOT analysis: promising pipeline drives stock outlook - Investing.com India

Oct 28, 2024
pulisher
Oct 28, 2024

Disc Medicine's (IRON) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Disc Medicine retains stock target, buy rating with positive CKD study data - Investing.com UK

Oct 28, 2024
pulisher
Oct 25, 2024

Disc Medicine Presents Positive Data from SAD Cohorts of a - GlobeNewswire

Oct 25, 2024
pulisher
Oct 25, 2024

Disc Medicine Reports Progress in Anemia Treatment Study By Investing.com - Investing.com Australia

Oct 25, 2024
pulisher
Oct 25, 2024

Disc Medicine Reports Progress in Anemia Treatment Study - Investing.com

Oct 25, 2024
pulisher
Oct 25, 2024

Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week - The Manila Times

Oct 25, 2024
pulisher
Oct 24, 2024

Disc Medicine's SWOT analysis: stock poised for growth amid clinical progress - Investing.com Australia

Oct 24, 2024
pulisher
Oct 24, 2024

Disc Medicine's SWOT analysis: stock poised for growth amid clinical progress By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Jefferies bullish on Disc Medicine, calls bitopertin a blockbuster in the making - Investing.com Canada

Oct 24, 2024
pulisher
Oct 23, 2024

Disc Medicine stock draws but at Jefferies (IRON:NASDAQ) - Seeking Alpha

Oct 23, 2024
pulisher
Oct 23, 2024

Disc Medicine appoints new chief technical officer - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer - The Manila Times

Oct 23, 2024
pulisher
Oct 23, 2024

Disc Medicine (NASDAQ:IRON) Now Covered by Analysts at Jefferies Financial Group - MarketBeat

Oct 23, 2024
pulisher
Oct 22, 2024

How To Trade (IRON) - Stock Traders Daily

Oct 22, 2024
pulisher
Oct 22, 2024

Sanctuary Advisors LLC Takes $68,000 Position in TCW Strategic Income Fund, Inc. (NYSE:TSI) - Defense World

Oct 22, 2024
pulisher
Oct 21, 2024

Disc Medicine, Inc. (NASDAQ:IRON) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

DocuSign (NASDAQ:DOCU) & Freshworks (NASDAQ:FRSH) Critical Review - Defense World

Oct 21, 2024
pulisher
Oct 17, 2024

Cantor Fitzgerald Reiterates Overweight Rating for Disc Medicine (NASDAQ:IRON) - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

Scotiabank Begins Coverage on Disc Medicine (NASDAQ:IRON) - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Tax incentives announced for life science companies in Mass. - WWLP.com

Oct 15, 2024
pulisher
Oct 15, 2024

Cantor Fitzgerald Reiterates "Overweight" Rating for Disc Medicine (NASDAQ:IRON) - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Degenerative Disc Disease Treatment Market Growth Analysis with Investment Opportunities For 2024-2033 - EIN News

Oct 14, 2024
pulisher
Oct 12, 2024

Marshall Wace LLP Sells 2,179 Shares of Twin Disc, Incorporated (NASDAQ:TWIN) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

The Manufacturers Life Insurance Company Grows Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World

Oct 12, 2024

Disc Medicine Inc (IRON) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):